YS Punekar, D Parks, M Joshi, S Kaur, L Evitt… - HIV …, 2021 - ncbi.nlm.nih.gov
Objectives Dolutegravir (DTG) is widely recommended within three‐drug regimens.
However, similar efficacy and tolerability have also been achieved with DTG within two‐drug …